Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis
Background: Patients with relapsing-remitting multiple sclerosis (RRMS) may experience acute relapses that are nonresponsive (20-35%) to...
Occupational Therapy Delivered Emotional Regulation Interventions: A Case-Series of Female Patients with Multiple Sclerosis
Background: Emotional health disorders are common in the Multiple Sclerosis (MS) population and can cause significant deficits in quality...
The Importance of Specialty Pharmacy Services in Multiple Sclerosis Patient Care
Background: Johns Hopkins Specialty Pharmacy provides clinical services for eligible multiple sclerosis (MS) patients on oral and...
Telehealth Utilization and Clinical Outcomes in Four MS Centers during the COVID Pandemic: Real-World Evidence from the MS-Cqi Improvement Research Collaborative.
Background: MS-CQI is the first multi-center improvement research collaborative for MS care. MS-CQI was a three-year study (2018-2020) to...
A Coach Supported Standardized Approach for Quality Improvement (QI) in the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative.
Background: MS-CQI is the first multicenter improvement research collaborative for MS. MS-CQI was a three-year study (2018-2020) of...
The Can Do Multiple Sclerosis Outcomes Study: Study Design to Evaluate Program Outcomes
Background: Assessment of self-efficacy has been a focus of Can Do MS programs given prior research showing associations between higher...
Evaluating the Impact of Fatigue Symptoms on Work Productivity and Activity Impairment Using Longitudinal Data from the Phase III Optimum Study
Background: Fatigue is a common symptom experienced by patients with Multiple Sclerosis (MS); and, the impact of fatigue on work...